We are grateful to Oud for his interest and comment [1] inquiring about the impact of the coronavirus disease 2019 (COVID-19) pandemic on the outcomes of patients enrolled in the COHO study [2]. Oud articulately highlighted that during the pandemic, there was: (1) a higher mortality rate in patients with hematologic malignancies admitted with COVID-19 compared to non-COVID19 diagnoses, and (2) an increased mortality in patients with non-COVID19 critical illness. He posits that both of these may have contributed to the long-term mortality and functional outcomes of COHO patients.

中文翻译：

---

血液系统恶性肿瘤危重患者的长期预后：2019 冠状病毒病大流行的影响是什么？作者的回复

我们感谢 Oud 的关注和评论 [1]，询问 2019 年冠状病毒病 （COVID-19） 大流行对 COHO 研究 [2] 入组患者预后的影响。Oud 清楚地强调，在大流行期间，存在：（1） 与非 COVID19 诊断相比，因 COVID-19 入院的血液系统恶性肿瘤患者的死亡率更高，以及 （2） 非COVID19危重症患者的死亡率增加。他认为，这两者都可能导致 COHO 患者的长期死亡率和功能结果。